Ergoterapeut Mette Thomsen ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 8.7% 10.2% 3.9% 3.5%  
Credit score (0-100)  0 30 25 50 51  
Credit rating  N/A BB BB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  0 0 0 0 0  
Gross profit  0.0 190 711 952 1,032  
EBITDA  0.0 36.4 235 297 241  
EBIT  0.0 36.4 235 278 236  
Pre-tax profit (PTP)  0.0 36.4 234.8 261.2 218.2  
Net earnings  0.0 28.2 182.7 201.0 168.4  
Pre-tax profit without non-rec. items  0.0 36.4 235 261 218  

 
See the entire income statement

Balance sheet (kDKK) 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Tangible assets total  0.0 0.0 0.0 449 477  
Shareholders equity total  0.0 78.2 207 297 353  
Interest-bearing liabilities  0.0 9.3 0.0 317 301  
Balance sheet total (assets)  0.0 121 265 715 830  

Net Debt  0.0 -67.5 -86.7 168 72.1  
 
See the entire balance sheet

Volume 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 190 711 952 1,032  
Gross profit growth  0.0% 0.0% 275.1% 33.9% 8.4%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 121 265 715 830  
Balance sheet change%  0.0% 0.0% 118.4% 170.1% 16.1%  
Added value  0.0 36.4 235.0 277.9 240.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 430 23  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 19.2% 33.1% 29.2% 22.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 30.1% 121.8% 56.7% 30.5%  
ROI %  0.0% 41.6% 159.6% 67.7% 37.2%  
ROE %  0.0% 36.1% 128.1% 79.7% 51.8%  

Solidity 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Equity ratio %  0.0% 64.6% 78.2% 41.6% 42.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -185.2% -36.9% 56.8% 30.0%  
Gearing %  0.0% 11.9% 0.0% 106.6% 85.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 4.8% 10.5% 5.7%  

Liquidity 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Quick Ratio  0.0 2.8 4.6 2.6 1.8  
Current Ratio  0.0 2.8 4.6 2.6 1.8  
Cash and cash equivalent  0.0 76.8 86.7 148.5 229.0  

Capital use efficiency 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 78.2 206.9 165.6 159.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 36 235 278 241  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 36 235 297 241  
EBIT / employee  0 36 235 278 236  
Net earnings / employee  0 28 183 201 168